LCN2 and thyroid cancer: Additionally, the use of molecular data for predict the prognostic of thyroid cancer patients remains controversial [42] and the identification of biomarkers with prognostic potential (as we describe here for C1QL1 and LCN2) can further improve the design of this kind of assays.